These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26806295)

  • 1. Over-expression of microRNA-375 inhibits papillary thyroid carcinoma cell proliferation and induces cell apoptosis by targeting ERBB2.
    Wang XZ; Hang YK; Liu JB; Hou YQ; Wang N; Wang MJ
    J Pharmacol Sci; 2016 Feb; 130(2):78-84. PubMed ID: 26806295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1.
    Cao XZ; Bin H; Zang ZN
    Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
    Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
    Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
    Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
    Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
    Xue KC; Hu DD; Zhao L; Li N; Shen HY
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-221 Exacerbate Cell Proliferation and Invasion by Targeting TIMP3 in Papillary Thyroid Carcinoma.
    Diao Y; Fu H; Wang Q
    Am J Ther; 2017 May; 24(3):e317-e328. PubMed ID: 27077469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
    Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
    Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
    Ma Y; Qin H; Cui Y
    Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over-expression of miR-206 decreases the Euthyrox-resistance by targeting MAP4K3 in papillary thyroid carcinoma.
    Liu F; Yin R; Chen X; Chen W; Qian Y; Zhao Y; Jiang Y; Ma D; Hu T; Yu T; Zhu Y; Zhang Y
    Biomed Pharmacother; 2019 Jun; 114():108605. PubMed ID: 30904818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-663 suppresses cell invasion and migration by targeting transforming growth factor beta 1 in papillary thyroid carcinoma.
    Wang Z; Zhang H; Zhang P; Dong W; He L
    Tumour Biol; 2016 Jun; 37(6):7633-44. PubMed ID: 26687649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1.
    Ma X; Wei J; Zhang L; Deng D; Liu L; Mei X; He X; Tian J
    Biomed Pharmacother; 2016 May; 80():220-226. PubMed ID: 27133060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
    Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
    Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α.
    Huang C; Cai Z; Huang M; Mao C; Zhang Q; Lin Y; Zhang X; Tang B; Chen Y; Wang X; Qian Z; Ye L; Peng Y; Xu H
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E204-13. PubMed ID: 25423566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-129 regulates growth and invasion by targeting MAL2 in papillary thyroid carcinoma.
    Gao X; Chen Z; Li A; Zhang X; Cai X
    Biomed Pharmacother; 2018 Sep; 105():1072-1078. PubMed ID: 30021343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
    Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
    Li R; Liu J; Li Q; Chen G; Yu X
    Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F8, a direct target of miR-144, promotes papillary thyroid cancer progression via regulating cell cycle.
    Sun J; Shi R; Zhao S; Li X; Lu S; Bu H; Ma X; Su C
    J Exp Clin Cancer Res; 2017 Mar; 36(1):40. PubMed ID: 28270228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid hormone receptor beta (THRB) is a major target gene for microRNAs deregulated in papillary thyroid carcinoma (PTC).
    Jazdzewski K; Boguslawska J; Jendrzejewski J; Liyanarachchi S; Pachucki J; Wardyn KA; Nauman A; de la Chapelle A
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E546-53. PubMed ID: 21159845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-200b/c-RAP1B axis represses tumorigenesis and malignant progression of papillary thyroid carcinoma through inhibiting the NF-κB/Twist1 pathway.
    Zhou B; Xu J; Chen Y; Gao S; Feng X; Lu X
    Exp Cell Res; 2020 Feb; 387(2):111785. PubMed ID: 31877303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.